ProAxsis announces strengthening of Board and Update on Strategy
ProAxsis announces strenghtening of Board and Update on Strategy To expedite Point of Care range in respiratory diagnostics ProAxsis Limited, the Belfast-based diagnostics company in respiratory disease, is pleased to announce that is has strengthened its Board and updated its corporate strategy in line with its next phase of growth and market opportunities. Described as […]
ProAxsis signs partnership agreement with US based Biotechnology company to develop two key respiratory proteases, utilizing ProteaseTag® technology, a platform technology that allows any protease to be targeted
ProAxsis and Queen’s University of Belfast secure a second licensing agreement for exclusive intellectual property rights ProteaseTag® technology
ProAxsis and Singapore based Kyberlife announce partnership
Measuring bone health with a new innovation for patients at high risk of osteoporotic fractures
Measuring bone health with a new innovation for patients at high risk of osteoporotic fractures ProAxsis is delighted to announce the approval of a key US patent for the underlying technology associated with its brand-new K-POSTN Assay, which the company intends to launch shortly. In partnership with the expert Bone Health team led by Professor […]
ProAxsis announces additional key appointments
As part of its continuing expansion, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce further key appointments within its Northern Ireland team. Dr Louise Ryan Murphy joins the company as Head of Business Operations. Louise brings a wealth of operational experience to ProAxsis, having previously held roles at Abbott Diagnostics, Horizon Discovery and […]
ProAxsis Ltd CEO Update Report – May 2021
ProAxsis Ltd CEO Update Report – May 2021 WP_Developer February 1, 2022 Recent Posts American Thoracic Society Annual Meeting Washington DC, 19-24 May 2023November 11, 2022 Association of Medical Diagnostics Manufacturers IVD Regulatory Meeting Bethesda, MD 19-20 April,2023November 11, 2022 Texas Lung Cancer Conference Austin, TX 30March – 1April 2023November 11, 2022 Have Any Questions? […]
ProAxsis enhances availability of product portfolio in Asia via new partnership with Kyberlife
ProAxsis Limited, the Belfast-based diagnostics company, today announces an expansion of its activities in Asia, via a partnership with Kyberlife, a Singapore-based company offering a novel e-commerce platform. The partnership will initially enable the company’s existing product portfolio, including laboratory-based assays for the active forms of Neutrophil Elastase and Proteinase 3, and a point-of-care test […]
ProAxsis expands inflammatory biomarker research via new partnership with Queen’s University Belfast
ProAxsis Limited, the Belfast-based diagnostics company, today announces that in partnership with Dr Rich Williams, a Senior Lecturer in the School of Medicine, Dentistry and BioMedical Sciences at Queen’s University Belfast, it has been successful in its application to the Collaborative Studentship competition. The collaborative project will involve recruitment of a PhD student to explore […]
ProAxsis establishes new internal Finance team
As part of its ongoing expansion plans, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce the appointment of Alison Gillan as its new Management Accountant. Alison Gillan joins the company as Management Accountant. Alison comes from private practice and has broad experience of in-house accounting within a wide range of businesses in many […]